Company profile for Hemogenyx Pharmaceuticals

NEW Drugs in Dev: 2
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located at its state-of-the-art research facility in New York City and a Belgian subsidiary, Hemogenyx-Cell SPRL, located in Liège. For more than 50 years, bone marrow transplantation has been used to save the lives of patients suffering from bl...
Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located at its state-of-the-art research facility in New York City and a Belgian subsidiary, Hemogenyx-Cell SPRL, located in Liège. For more than 50 years, bone marrow transplantation has been used to save the lives of patients suffering from blood diseases. The risks of toxicity and death that are associated with bone marrow transplantation, however, have meant that the procedure is restricted to use only as a last resort.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
5 Fleet Place, London, EC4M 7RD
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-12-22/hemogenyx-pharmaceuticals-plc-announces-update-on-admission-of-shares

PHARMIWEB
22 Dec 2025
Hemogenyx Pharma PLC Issues Equity
Hemogenyx Pharma PLC Issues Equity

18 Dec 2025

// PHARMIWEB

https://www.pharmiweb.com/press-release/2025-12-18/hemogenyx-pharmaceuticals-plc-issue-of-equity

PHARMIWEB
18 Dec 2025

https://www.pharmiweb.com/press-release/2025-11-19/hemogenyx-pharmaceuticals-plc-announces-publication-of-prospectus

PHARMIWEB
19 Nov 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/hemogenyx-pharmaceuticals-plc-announces-clinical-trial-update-and-gra-1093023

ACCESSWIRE
29 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-06/hemogenyx-pharmaceuticals-plc-announces-clearance-to-initiate-pediatric-enrolment

PHARMAWEB
06 Oct 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/hemogenyx-pharmaceuticals-plc-announces-half-year-report-1079827

ACCESSWIRE
30 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty